Primary Record
Rovazolac
- In stock
- 5,650 g
- Purity
- 98.7 %
- CAS
- 1454288-88-0
Compound Identifiers & Properties
- CAS
- 1454288-88-0
- PubChem CID
- 89792952
- SMILES
- CCOC(=O)CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)C
- Canonical SMILES
- CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1
Names & Synonyms
- Rovazolac
- Pagibaximab
- pagibaximabum
- Rovazolac [INN]
- 1454288-88-0
- ROVAZOLAC [USAN]
- RefChem:858292
- PAGIBAXIMAB [INN]
- Pagibaximab [USAN:INN]
- PAGIBAXIMAB [USAN]
- ALX-101
- W51K389XIL
- UNII-W51K389XIL
- BSYX-A110
- ZUMNJDGBYXHASJ-UHFFFAOYSA-N
- 23KB56UHN9
- BSYX-A 110
- GTPL9625
- orb1706691
- C21H19F3N2O4S
- CHEMBL4297218
- SCHEMBL15242823
- DTXSID801122584
- DTXSID901054118
- MFCD31657370
- AKOS040742578
- (trifluoromethyl)-1H-pyrazol-1-yl}acetate
- example 36 [WO2013130892]
- A-110
- DA-77543
- MS-28220
- HY-109073
- CS-0033536
- G16303
- A999985
- ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate
- ethyl {5-[3'-(methanesulfonyl)[1,1'-biphenyl]-4-yl]-3-
- 595566-61-3
- ethyl 2-(5-(3'-(methylsulfonyl)biphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
- 1H-PYRAZOLE-1-ACETIC ACID, 5-(3'-(METHYLSULFONYL)(1,1'-BIPHENYL)-4-YL)-3-(TRIFLUOROMETHYL)-, ETHYL ESTER
- ETHYL (5-(3'-(METHANESULFONYL)(1,1'-BIPHENYL)-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)ACETATE
- Ethyl {5-[3'-(methanesulfonyl)[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazol-1-yl}acetate
- Ethyl 2-(5-(3'-(methylsulfonyl)-(1,1'-biphenyl)-4-yl)-3-(trifluoromethyl)-1hpyrazol-1-yl)acetate
- ethyl 2-(5-(3'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
- Ethyl 2-[5-[3 inverted exclamation marka-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetate
- Ethyl 2-[5-[3a(2)-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetate
- IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
- IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 KAPPA-CHAIN, DIMER
- IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
- IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 KAPPA-CHAIN, DIMER
- Immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid) (human-mouse monoclonal heavy chain), disulfide with human-mouse monoclonal kappa-chain, dimer
- IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
- Immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid)(human-mouse monoclonal heavy chain), disulfide with human-mouse monoclonal kappa-chain, dimer
- IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
- IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL KAPPA-CHAIN, DIMER